BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
종목 코드 BGLC
회사 이름BioNexus Gene Lab Corp
상장일Mar 11, 2020
CEOMr. Lee Su-Leng Tan
직원 수30
유형Ordinary Share
회계 연도 종료Mar 11
주소10-2 Tower B, Vertical Business Suite
도시KUALA LUMPUR
증권 거래소NASDAQ Capital Market Consolidated
국가Malaysia
우편 번호59200
전화13072416898
웹사이트https://www.bionexusgenelab.com/
종목 코드 BGLC
상장일Mar 11, 2020
CEOMr. Lee Su-Leng Tan
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음